{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:58:37Z","timestamp":1769115517080,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:00:00Z","timestamp":1468800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Alzheimers Society UK","award":["184"],"award-info":[{"award-number":["184"]}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["184"],"award-info":[{"award-number":["184"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13063-016-1449-3","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T09:04:31Z","timestamp":1468832671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol"],"prefix":"10.1186","volume":"17","author":[{"name":"AFFECT Investigators","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Greenan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ly-Mee","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick G.","family":"Kehoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Coulthard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Bath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rob","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Arrojo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Canning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Wallach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernadette","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clive","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Passmore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"key":"1449_CR1","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer\u2019s Report 2010. The Global Economic Impact of Dementia. London: Alzheimer\u2019s Disease International; 2010."},{"key":"1449_CR2","first-page":"CD004395","volume":"1","author":"R Malouf","year":"2004","unstructured":"Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev. 2004;1:CD004395.","journal-title":"Cochrane Database Syst Rev"},{"key":"1449_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0022-510X(02)00252-6","volume":"203\u2013204","author":"GC Rom\u00e1n","year":"2002","unstructured":"Rom\u00e1n GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci. 2002;203\u2013204:7\u201310.","journal-title":"J Neurol Sci"},{"key":"1449_CR4","doi-asserted-by":"crossref","unstructured":"O\u2019Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. Lancet Neurol. 2003;2:89\u201398.","DOI":"10.1016\/S1474-4422(03)00305-3"},{"key":"1449_CR5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1136\/jnnp.60.4.431","volume":"60","author":"S Tarvonen-Schr\u00f6der","year":"1996","unstructured":"Tarvonen-Schr\u00f6der S, R\u00f6ytt\u00e4 M, R\u00e4ih\u00e4 I, Kurki T, Rajala T, Sourander L. Clinical features of leuko-araiosis. J Neurol Neurosurg Psychiatry. 1996;60:431\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1449_CR6","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMp068043","volume":"354","author":"SM Greenberg","year":"2006","unstructured":"Greenberg SM. Small vessels, big problems. N Engl J Med. 2006;354:1451\u20133.","journal-title":"N Engl J Med"},{"key":"1449_CR7","first-page":"CD000147","volume":"3","author":"J Lopez-Arrieta","year":"2009","unstructured":"Lopez-Arrieta J, Birks J. Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev. 2009;3:CD000147.","journal-title":"Cochrane Database Syst Rev"},{"key":"1449_CR8","unstructured":"Dorn M. Effect of nimodipine on the wellbeing, symptoms and efficacy of ambulatory patients with cerebrovascular disorders. In: Betz E, Deck K, Hoffmeister F, editors. Nimodipine. Pharmacological and clinical properties, Proceedings of the First International Symposium. New York: Stuttgart; 1985. p. 295\u2013304."},{"key":"1449_CR9","doi-asserted-by":"crossref","unstructured":"Fischhof PK, Wagner G, Littschauer L, R\u00fcther E, Apecechea M, Hiersemenzel R, R\u00f6hmel J, Hoffmeister F, Schmage N. Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia. In: Bergener M, Reisberg B, editors. Diagnosis and treatment of senile dementia. New York: Springer; 1989. p. 350\u20139.","DOI":"10.1007\/978-3-642-46658-8_27"},{"key":"1449_CR10","doi-asserted-by":"crossref","unstructured":"Pantoni L, Rossi R, Inzitari D, Bianchi C, Beneke M, Erkinjuntti T, Wallin A. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial. J Neurol Sci. 2000;175:124\u201334.","DOI":"10.1016\/S0022-510X(00)00300-2"},{"key":"1449_CR11","doi-asserted-by":"crossref","unstructured":"Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A, VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet. 2004;363:2022\u201331.","DOI":"10.1016\/S0140-6736(04)16451-9"},{"key":"1449_CR12","doi-asserted-by":"crossref","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J, ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895\u2013906.","DOI":"10.1016\/S0140-6736(05)67185-1"},{"key":"1449_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/HYPERTENSIONAHA.107.089763","volume":"50","author":"JG Wang","year":"2007","unstructured":"Wang JG, Li Y, Franklin SS, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview. Hypertension. 2007;50:181\u20138.","journal-title":"Hypertension"},{"key":"1449_CR14","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","volume":"338","author":"MR Law","year":"2009","unstructured":"Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.","journal-title":"BMJ"},{"key":"1449_CR15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/j.1471-4159.2011.07529.x","volume":"119","author":"YJ Lee","year":"2011","unstructured":"Lee YJ, Park HH, Koh SH, Choi NY, Lee KY. Amlodipine besylate and amlodipine camsylate prevent cortical neuronal cell death induced by oxidative stress. J Neurochem. 2011;119:1262\u201370.","journal-title":"J Neurochem"},{"key":"1449_CR16","doi-asserted-by":"crossref","unstructured":"Watfa G, Rossignol P, Kearney-Schwartz A, Fay R, Felblinger J, Boivin JM, Lacolley P, Zannad F, Benetos A. Use of calcium channel blockers is associated with better cognitive performance in older hypertensive patients with subjective memory complaints. J Hypertens. 2010;12:2485\u201393.","DOI":"10.1016\/j.artres.2010.10.108"},{"key":"1449_CR17","doi-asserted-by":"crossref","unstructured":"Ylikoski R, Jokinen H, Andersen P, Salonen O, Madureira S, Ferro J, Barkhof F, van der Flier W, Schmidt R, Fazekas F, Scheltens P, Waldemar G, Salvadori E, Pantoni L, Inzitari D, Erkinjuntti T, LADIS Study Group. Comparison of the Alzheimer\u2019s Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study. Dement Geriatr Cogn Disord. 2007;24:73\u201381.","DOI":"10.1159\/000103865"},{"key":"1449_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1017\/S1041610297004754","volume":"9","author":"DW Molloy","year":"1997","unstructured":"Molloy DW, Standish TI. A guide to the standardised Mini-Mental State Examination. Int Psychogeriatr. 1997;9:87\u201394.","journal-title":"Int Psychogeriatr"},{"key":"1449_CR19","unstructured":"Reitan RM. Trail Making Test: Manual for the Administration and Scoring of the Trail Making Test. Bloomington: Indiana University; 1959."},{"key":"1449_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/gps.830","volume":"18","author":"CA Jager de","year":"2003","unstructured":"de Jager CA, Budge MM, Clarke R. Utility of TICS-M for the assessment of cognitive function in older adults. Int J Geriatr Psychiatry. 2003;18:318\u201324.","journal-title":"Int J Geriatr Psychiatry"},{"key":"1449_CR21","doi-asserted-by":"crossref","unstructured":"Schneider LS, Clark CM, Doody R, Ferris SH, Morris JC, Raman R, Reisberg B, Schmitt FA. ADCS Prevention Instrument Project: ADCS-clinicians\u2019 global impression of change scales (ADCS-CGIC), self-rated and study partner-rated versions. Alzheimer Dis Assoc Disord. 2006;20(4 Suppl 3):S124\u201338.","DOI":"10.1097\/01.wad.0000213878.47924.44"},{"key":"1449_CR22","first-page":"199","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"EuroQol Group. EuroQoL \u2013 a new facility for the measurement of health-related quality of life. Policy. 1990;16:199\u2013208.","journal-title":"Policy"},{"key":"1449_CR23","doi-asserted-by":"crossref","unstructured":"Smith SC, Lamping DL, Banerjee S, Harwood R, Foley B, Smith P, Cook JC, Murray J, Prince M, Levin E, Mann A, Knapp M. Measurement of health-related quality of life for people with dementia: development of a new instrument (DEMQOL) and an evaluation of current methodology. Health Technol Assess. 2005;9:1\u201393.","DOI":"10.3310\/hta9100"},{"key":"1449_CR24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.5014\/ajot.53.5.471","volume":"53","author":"I G\u00e9linas","year":"1999","unstructured":"G\u00e9linas I, Gauthier L, McIntyre M, Gauthier S. Development of a functional measure for persons with Alzheimer\u2019s disease: the disability assessment for dementia. Am J Occup Ther. 1999;53:471\u201381.","journal-title":"Am J Occup Ther"},{"key":"1449_CR25","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308\u201314.","journal-title":"Neurology"},{"key":"1449_CR26","doi-asserted-by":"crossref","unstructured":"Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gueje O, Rutter C. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychol Med. 1997;27:191\u20137.","DOI":"10.1017\/S0033291796004242"},{"key":"1449_CR27","unstructured":"Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, editor. Measuring Mental Health Needs. 2nd ed. London: Gaskell; 2001. p. 200\u201324."},{"key":"1449_CR28","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000."},{"key":"1449_CR29","doi-asserted-by":"crossref","unstructured":"Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transmission. 2000;59:23\u201330.","DOI":"10.1007\/978-3-7091-6781-6_4"},{"key":"1449_CR30","doi-asserted-by":"crossref","unstructured":"Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sj\u00f6gren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P. European Task Force on age-related white matter changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32:1318\u201322.","DOI":"10.1161\/01.STR.32.6.1318"},{"key":"1449_CR31","doi-asserted-by":"crossref","unstructured":"Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology. 1993;43:1683\u20139.","DOI":"10.1212\/WNL.43.9.1683"},{"key":"1449_CR32","doi-asserted-by":"crossref","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge RV, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M. STandards for ReportIng Vascular changes on Euroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822\u201338.","DOI":"10.1016\/S1474-4422(13)70124-8"},{"key":"1449_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1017\/S1041610203009323","volume":"1","author":"F Barkhof","year":"2003","unstructured":"Barkhof F. Guidelines for brain imaging in vascular dementia clinical trials. Int Psychogeriatr. 2003;1:273\u20136.","journal-title":"Int Psychogeriatr"},{"key":"1449_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jval.2012.09.008","volume":"16","author":"E Marques","year":"2013","unstructured":"Marques E, Johnson EC, Gooberman-Hill R, Blom AW, Noble S. Using resource use logs to reduce the amount of missing data in economic evaluations alongside trials. Value Health. 2013;16:195\u2013201.","journal-title":"Value Health."},{"key":"1449_CR35","doi-asserted-by":"crossref","unstructured":"Dichgans M, Markus HS, Salloway S, Verkkoniemi A, Moline M, Wang Q, Posner H, Chabriat HS. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol. 2008;7:310\u20138.","DOI":"10.1016\/S1474-4422(08)70046-2"},{"key":"1449_CR36","doi-asserted-by":"publisher","first-page":"c332","DOI":"10.1136\/bmj.c332","volume":"340","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332.","journal-title":"BMJ"},{"key":"1449_CR37","doi-asserted-by":"crossref","unstructured":"Rowen D, Mulhern B, Banerjee S, Hout B, Young TA, Knapp M, Smith SC, Lamping DL, Brazier JE. Estimating preference-based single index measures for dementia using DEMQOL and DEMQOL-Proxy. Value Health. 2012;15:346\u201356.","DOI":"10.1016\/j.jval.2011.10.016"},{"key":"1449_CR38","unstructured":"Dolan P, Gudex C, Kind P, Williams A. A social tariff for EuroQol: results from a UK general population survey. York: University of York; 1995."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1449-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-016-1449-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1449-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-016-1449-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T14:38:49Z","timestamp":1498315129000},"score":1,"resource":{"primary":{"URL":"http:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-016-1449-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1449"],"URL":"https:\/\/doi.org\/10.1186\/s13063-016-1449-3","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]},"article-number":"324"}}